Physician profile
Samit Shah
NPI 1003040254
$12,457.57
in general payments reported to CMS, 2019-2025
8 companies · $10K in 2025
The $10K reported for 2025 was more than what 77% of Advanced Heart Failure and Transplant Cardiology providers received nationally (typical 2025 total: $1,046).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $211 · 2020: $1,188 · 2021: $174 · 2023: $190 · 2024: $296 · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $9,750 · Food and Beverage: $1,087 · Travel and Lodging: $47.48.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $9,750.00 |
| Food and Beverage | $1,087.17 |
| Travel and Lodging | $47.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $11,877.70 | 2019-2025 | Optis, Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit |
| Alnylam Pharmaceuticals INC. | $190.23 | 2025 | Onpattro, Amvuttra |
| Cvrx, INC. | $142.65 | 2024 | Barostim Neo System |
| Boston Scientific Corporation | $120.10 | 2020 | |
| Impulse Dynamics (USA) INC. | $42.82 | 2025 | Optimizer |
| Medtronic Vascular, INC. | $35.54 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $26.86 | 2019-2025 | Camzyos |
| Bayer Healthcare Pharmaceuticals INC. | $21.67 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samit Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.